Literature DB >> 23515539

Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.

Alexander H Dalpke1, Marjeta Hofko, Markus Zorn, Stefan Zimmermann.   

Abstract

We evaluated the fully automated molecular BD MAX Cdiff assay (BD Diagnostics) and the Xpert C. difficile test (Cepheid) for rapid detection of Clostridium difficile infection. Culture was done on chromogenic agar followed by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry identification and toxin detection. Repeat testing was required for 1.8% and 6.0% of the BD MAX and Xpert tests, respectively. Sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) were 90.5%, 97.9%, 89.3%, and 98.1%, respectively, for BD MAX and 97.3%, 97.9%, 90.0%, and 99.5%, respectively, for Xpert.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23515539      PMCID: PMC3716071          DOI: 10.1128/JCM.00344-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Evaluation of diagnostic tests for Clostridium difficile infection.

Authors:  Jonathan Swindells; Nigel Brenwald; Nathan Reading; Beryl Oppenheim
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

2.  Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions.

Authors:  Luis G Arroyo; Joyce Rousseau; Barbara M Willey; Don E Low; Henry Staempfli; Allison McGeer; J Scott Weese
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Authors:  Fred C Tenover; Susan Novak-Weekley; Christopher W Woods; Lance R Peterson; Thomas Davis; Paul Schreckenberger; Ferric C Fang; Andre Dascal; Dale N Gerding; Jim H Nomura; Richard V Goering; Thomas Akerlund; Alice S Weissfeld; Ellen Jo Baron; Edith Wong; Elizabeth M Marlowe; Joseph Whitmore; David H Persing
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

4.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

6.  Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.

Authors:  Kerrie Eastwood; Patrick Else; André Charlett; Mark Wilcox
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

Review 7.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

Authors:  M J T Crobach; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

8.  Evaluation of the chromogenic agar chromID C. difficile.

Authors:  Catherine Eckert; Béatrice Burghoffer; Valérie Lalande; Frederic Barbut
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

9.  Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.

Authors:  Haihui Huang; Andrej Weintraub; Hong Fang; Carl Erik Nord
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

Review 10.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

View more
  12 in total

1.  Comparison of GenomEra C. difficile and Xpert C. difficile as confirmatory tests in a multistep algorithm for diagnosis of Clostridium difficile infection.

Authors:  Luis Alcalá; Elena Reigadas; Mercedes Marín; Antonia Fernández-Chico; Pilar Catalán; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.

Authors:  Thais Simões Camargo; Moacyr Silva Junior; Luis Fernando Aranha Camargo; Veronica Pivetta Biotto; André Mario Doi; Paula Celia Mariko Koga; Carolina Nunes França; Marines Dalla Valle Martino
Journal:  Arch Microbiol       Date:  2021-01-18       Impact factor: 2.552

3.  Combination of culture, antigen and toxin detection, and cytotoxin neutralization assay for optimal Clostridium difficile diagnostic testing.

Authors:  Michelle J Alfa; Shadi Sepehri
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Discrimination of Human Pathogen Clostridium Species Especially of the Heterogeneous C. sporogenes and C. botulinum by MALDI-TOF Mass Spectrometry.

Authors:  Reiner Schaumann; Kevin Dallacker-Losensky; Christiane Rosenkranz; Gelimer H Genzel; Catalina S Stîngu; Wolfgang Schellenberger; Sebastian Schulz-Stübner; Arne C Rodloff; Klaus Eschrich
Journal:  Curr Microbiol       Date:  2018-08-17       Impact factor: 2.188

5.  Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR.

Authors:  L Martínez Lamas; M T Pérez Rodríguez; I Álvarez Ramos; M E Bouza Soage; M P Figueroa Lamas; M Álvarez Fernández
Journal:  Rev Esp Quimioter       Date:  2018-06-29       Impact factor: 1.553

6.  Performance Evaluation of the Luminex Aries C. difficile Assay in Comparison to Two Other Molecular Assays within a Multihospital Health Care Center.

Authors:  Stefan Juretschko; Ryhana Manji; Reeti Khare; Shubhagata Das; Sherry Dunbar
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

7.  Ambulatory-treated Clostridium difficile infection: a comparison of community-acquired vs. nosocomial infection.

Authors:  T Delate; G Albrecht; K Won; A Jackson
Journal:  Epidemiol Infect       Date:  2014-07-24       Impact factor: 4.434

8.  Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.

Authors:  Bo-Moon Shin; Sun Mee Yoo; Won Chang Shin
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

9.  Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis.

Authors:  Yuanyuan Bai; Xiaorong Sun; Yan Jin; Yueling Wang; Juan Li
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

10.  Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.

Authors:  Paul A Granato; Glen Hansen; Emily Herding; Sheena Chaudhuri; Shaowu Tang; Sachin K Garg; Catherine R Rowell; Joanna Jackson Sickler
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.